What are the signs that your lab has outgrown manual sample preparation?

Your lab has outgrown manual sample preparation when the process itself becomes the bottleneck, when staff are spending more time pipetting, evaporating, and cleaning glassware than on actual analysis, and when sample throughput can no longer keep pace with incoming workload. This is especially true for laboratories analyzing persistent organic pollutants such as dioxins, PCBs, and PFAS, where manual cleanup steps are both time-consuming and technically demanding. The sections below address the most common signs, risks, and decision points that signal it is time to make the switch to automated sample preparation.

How does manual sample preparation slow down high-throughput labs?

Manual sample preparation slows down high-throughput labs because every step, extraction, cleanup, evaporation, and fraction collection, depends on a technician’s time and attention. When sample volumes grow, the bottleneck does not just widen; it multiplies. Each additional sample means more hands-on hours, more waiting, and more opportunity for delays that ripple across the entire analytical workflow.

In a high-throughput environment, the problem compounds quickly. A technician performing manual liquid-liquid extraction or column cleanup can realistically process only a handful of samples per day. Meanwhile, the analytical instruments, GC-MS, HRGC-HRMS, sit underutilized, waiting for samples that are still being prepared. The result is a lab where expensive equipment is idle and skilled staff are occupied with repetitive, low-value tasks instead of analytical work or method development.

There is also the issue of sequencing. Manual preparation is largely linear: one step must finish before the next begins. Automated systems can run multiple sequences simultaneously, dramatically compressing the time between sample receipt and reportable result. For labs under pressure to turn around results quickly, whether for regulatory compliance or commercial contract deadlines, this difference in throughput is not marginal; it is decisive.

What are the most common signs of manual sample prep bottlenecks?

The most common signs of a manual sample preparation bottleneck are a growing backlog of unprocessed samples, staff regularly working overtime on preparation tasks, inconsistent turnaround times, and analytical instruments sitting idle while samples are still being processed. These symptoms indicate that the preparation workflow can no longer match the lab’s analytical capacity.

Beyond the obvious throughput problems, there are subtler indicators worth monitoring:

Staff fatigue and high error rates: When technicians perform the same repetitive steps for hours, concentration lapses. Errors in manual sample preparation, mislabeling, incorrect volumes, missed steps, tend to increase as workload rises.
Inconsistent results between operators: If the same sample type produces different results depending on who prepared it, manual variability is likely the cause.
Inability to accept new contracts: When a lab turns down work or extends lead times because preparation capacity is the limiting factor, that is a direct financial signal that the current workflow has reached its ceiling.
Disproportionate time spent on cleanup steps: For analyses involving dioxins, PCBs, or PFAS, multi-layer column cleanup is particularly labor-intensive manually. If cleanup alone consumes the majority of preparation time, automation delivers the greatest return.
Frequent instrument downtime caused by dirty extracts: Poorly cleaned samples that reach the GC or LC cause contamination, increase maintenance frequency, and reduce instrument lifetime, all traceable back to insufficient or inconsistent manual cleanup.

Why do manual methods increase contamination and reproducibility risks?

Manual sample preparation increases contamination and reproducibility risks because every human interaction with a sample introduces a potential source of error or contamination. Open vessels, shared glassware, airborne particles, and variable technique between operators all create conditions where results can drift, even when analysts follow the same written procedure.

Cross-contamination is a particular concern in laboratories analyzing trace-level pollutants. When analyzing dioxins or PCBs at picogram levels, even minor carryover from a previous high-concentration sample can compromise results. In manual workflows, the risk of carryover exists at every transfer step, every pipette, every funnel, every column. Cleaning protocols help, but they rely on consistent human execution.

Reproducibility suffers for a related reason: manual techniques are inherently operator-dependent. Flow rates through SPE columns, contact times during extraction, and evaporation endpoints are all subject to individual judgment. Two technicians following the same protocol may produce systematically different recoveries without either making an obvious mistake. Over time, this variability undermines method validation data and can jeopardize ISO 17025 accreditation, where measurement uncertainty must be demonstrably controlled.

Automated systems address both problems structurally. When samples do not come into direct contact with the instrument, as is the case with fully closed-path automated cleanup platforms, cross-contamination risk is eliminated by design, not just managed by protocol. Reproducibility improves because every sample follows an identical, programmable sequence with no operator-to-operator variation.

When does solvent consumption become a sign of an inefficient workflow?

Solvent consumption becomes a sign of an inefficient workflow when the volume used per sample is disproportionate to what modern methods require, or when solvent handling, disposal, and safety costs are consuming a significant share of the lab’s operating budget. High solvent use is both an environmental liability and a direct indicator that the preparation process has not been optimized.

In traditional manual extraction and cleanup procedures for persistent organic pollutants, solvent volumes per sample can be substantial, often several hundred milliliters or more when liquid-liquid extraction, column cleanup, and concentration steps are combined. Dichloromethane, historically common in dioxin and PCB analysis, carries additional regulatory and occupational health burdens that add cost and complexity beyond the solvent itself.

Modern automated sample preparation systems are specifically engineered to reduce this waste. Fully automated cleanup platforms can process samples using less than 100 ml of organic solvent per sample without requiring dichloromethane at all. When a lab’s current solvent consumption sits well above this threshold, it is a measurable sign that the workflow has room for significant improvement, both in cost efficiency and environmental impact.

For laboratories operating under sustainability mandates or preparing for stricter chemical waste regulations, solvent reduction is not just an efficiency metric; it is a compliance consideration. Tracking solvent use per sample over time is a straightforward way to quantify the gap between current practice and what optimized automated workflows can deliver.

What’s the difference between partially automated and fully automated sample preparation?

Partially automated sample preparation automates one or a few steps in the workflow, such as SPE extraction or evaporation, while other steps remain manual. Fully automated sample preparation integrates the entire sequence, from extraction through cleanup and concentration, into a single unattended platform that requires minimal operator intervention.

Partial automation: targeted efficiency gains

Partial automation is often a lab’s first step away from fully manual workflows. An automated SPE system, for example, can handle cartridge conditioning, sample loading, washing, and elution without manual pipetting, freeing the operator for other tasks during the run. Similarly, automated evaporation systems remove the need to monitor and manually stop concentration steps. These improvements are real and meaningful, particularly for labs with limited budgets or those processing a narrow range of sample types. Systems like the SPE2000 bring this kind of targeted automation to PFAS, pesticide, and SVOC workflows, processing up to 80 samples per run.

Full automation: end-to-end workflow integration

Fully automated sample preparation eliminates manual handoffs between steps. In a fully automated dioxin or PCB workflow, for instance, the system handles extraction, multi-layer column cleanup, fraction collection, and solvent reduction in a continuous, programmed sequence. The operator loads samples and retrieves purified extracts ready for instrumental analysis; the intervening steps run unattended, often overnight. This level of integration is what enables high-throughput labs to scale sample volume without scaling headcount proportionally.

The practical distinction matters when evaluating where bottlenecks actually sit. If extraction is the limiting step, automating only cleanup provides limited relief. A thorough workflow audit, mapping time spent at each stage, is the most reliable way to determine whether partial automation addresses the real constraint or whether full integration is needed.

How do you know when it’s time to switch to an automated system?

It is time to switch to an automated sample preparation system when the manual workflow consistently limits throughput, introduces unacceptable variability, generates excessive solvent waste, or prevents the lab from meeting turnaround commitments. The decision becomes urgent when these problems persist despite process improvements and additional staffing.

Several concrete decision triggers indicate readiness for automation:

Throughput ceiling has been reached: The lab cannot increase sample output without a proportional increase in preparation staff, and hiring is not a viable or sustainable solution.
Method validation data shows operator-dependent variability: Recovery rates or measurement uncertainty differ significantly between analysts, and training alone has not resolved the gap.
Regulatory or accreditation pressure is increasing: ISO 17025 audits, EU regulatory requirements, or client specifications are demanding tighter control over measurement uncertainty than manual methods can reliably deliver.
Solvent costs and waste disposal fees are rising: The lab is using high volumes of regulated solvents, and the associated handling, storage, and disposal costs are growing faster than revenue.
The lab is expanding its contaminant scope: Adding PFAS to an existing dioxin and PCB menu, for example, typically requires dedicated SPE workflows that are far more practical to implement as automated systems from the outset.

The timing of the investment also matters. Waiting until the workflow is fully overwhelmed means absorbing months of inefficiency before the new system is operational. Labs that evaluate automation proactively, when throughput is growing but not yet critical, can implement and validate new systems without the pressure of a backlog crisis.

How DSP-Systems helps labs move beyond manual sample preparation

DSP-Systems supplies and configures automated sample preparation systems specifically designed for laboratories analyzing environmental contaminants, including dioxins, PCBs, PFAS, and pesticides. Their solutions directly address the bottlenecks, contamination risks, and solvent inefficiencies that signal a lab has outgrown its manual workflow:

Fully automated cleanup: The GO-EHT platform purifies samples for dioxin, PCB, PBDE, and PCN analysis with less than 100 ml of solvent per sample, no dichloromethane, and zero cross-contamination risk thanks to a closed-path design.
High-capacity SPE automation: The SPE2000 processes up to 80 samples per run across a wide range of cartridge sizes, covering PFAS, pesticides, hormones, PAHs, and other emerging contaminants.
Large-volume water extraction: The AutoEmpore handles high-throughput water sample extraction in 3- to 12-channel configurations with automatic filtration and water removal.
Integrated extraction and concentration: The SER-158 extractor and CentriVap concentration system complement automated cleanup platforms for a complete, end-to-end preparation workflow.
Method development and validation support: DSP-Systems works alongside laboratories to configure systems in line with EPA and CEN standards and to validate methods for ISO 17025 compliance.

If your lab is experiencing any of the signs described in this article, contact DSP-Systems to discuss which automated sample preparation solution fits your matrix types, contaminant scope, and throughput requirements.

Veelgestelde vragen

How long does it typically take to validate an automated sample preparation system for ISO 17025 compliance?

Validation timelines vary depending on the complexity of the matrix and the number of analytes, but most laboratories can expect the process to take between 4 and 12 weeks when working with a supplier that provides method development support. This includes initial system configuration, spike recovery trials, reproducibility testing across multiple operators and days, and documentation of measurement uncertainty. Working with a supplier experienced in EPA and CEN standard methods, as DSP-Systems does, can significantly compress this timeline by providing pre-validated method templates as a starting point.

Can automated sample preparation systems handle multiple matrix types, or do we need separate systems for water, soil, and biological samples?

Most modern automated platforms are configurable for multiple matrix types, though the specific hardware and method parameters will differ between, for example, aqueous samples and solid matrices like soil or tissue. Systems like the AutoEmpore are purpose-built for large-volume water extraction, while platforms such as the GO-EHT and SPE2000 can be configured across a broader range of matrices. The practical approach is to map your current matrix portfolio and discuss with your supplier which platform or combination of platforms covers your scope without unnecessary redundancy.

What happens to our existing manual methods when we switch to automation — do they need to be completely rewritten?

Existing methods do not need to be rewritten from scratch, but they do need to be adapted and revalidated for the automated platform. The core chemistry, extraction principles, and cleanup sequences typically remain the same; what changes is how those steps are executed and controlled. In practice, automation often improves upon manual methods by tightening flow rates, contact times, and solvent volumes, which can actually enhance recovery consistency rather than simply replicating what was done manually.

How do we build a business case for automation when the upfront investment is significant?

The most effective business case quantifies the hidden costs of manual preparation that are already being absorbed: technician hours spent on preparation versus analysis, overtime costs, solvent purchasing and disposal fees, instrument downtime caused by dirty extracts, and revenue lost from declined contracts or extended lead times. When these are totaled and compared against the amortized cost of an automated system, the return on investment period is often shorter than expected — frequently under two years for high-throughput labs. Including projected revenue from increased sample capacity strengthens the case further and reframes the investment as a growth enabler rather than a cost.

Is it possible to automate only the cleanup step if our extraction process is already working well?

Yes, and this is a common and practical entry point for labs that have already optimized their extraction workflow. Automating the cleanup step alone, particularly for multi-layer column cleanup in dioxin, PCB, or PFAS analysis, can deliver substantial throughput and reproducibility gains without replacing the entire workflow. The key is to perform a honest bottleneck audit first: if cleanup is genuinely the limiting step, targeted automation there will have the greatest impact; if extraction is equally constrained, partial automation may only shift the bottleneck rather than eliminate it.

What are the most common mistakes labs make when first implementing automated sample preparation?

The most common mistakes are underestimating the importance of staff training, skipping a thorough workflow audit before selecting a system, and assuming that automation will compensate for upstream problems like inconsistent sample collection or storage. Automation standardizes what happens inside the system, but it cannot correct for variability introduced before the sample reaches the platform. Investing time upfront in proper system configuration, operator training, and a realistic validation plan is what separates a smooth implementation from one that creates new problems while solving old ones.

How do automated systems handle the risk of carryover between samples, especially when processing high-concentration and trace-level samples in the same batch?

Well-designed automated systems address carryover through closed-path fluidics, automated solvent rinse cycles between samples, and in some cases dedicated single-use flow paths or cartridges that are never shared between samples. Platforms like the GO-EHT use a closed-path design that eliminates cross-contamination by preventing direct contact between the sample and reusable instrument surfaces. For labs running mixed batches with large concentration ranges, it is worth discussing batch sequencing strategies with your supplier, as running low-concentration samples before high-concentration ones and including procedural blanks at defined intervals are best practices that apply regardless of automation level.

Gerelateerde artikelen

Deze inhoud is gegenereerd met behulp van AI en kan fouten bevatten.